Cash flow EUROAPI

Stocks

EAPI

FR0014008VX5

Pharmaceuticals

Real-time Euronext Paris 11:35:16 2026-10-06 EDT			5-day change	1st Jan Change
0.7470 ^EUR	+2.19%		+1.36%	-67.09%

09-20	Euroapi S.A.(ENXTPA:EAPI) dropped from S&P Global BMI Index	CI
07-30	Euroapi S.A., Q2 2026 Earnings Call, Jul 30, 2026

f75aacafaf9078bfc3.0blR9yeZL2jdR1MkjIG80-eN224ouhT27aFgAMh9yuU.uNgbkUbPSzqMGBxL48n2qaj-vFxygkSlpv4uYZpOqYOXzWG4YetFDKooBg

Published financial data: EUROAPI

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	893M	977M	1.01B	912M	848M
Other Revenues, Total	-	4.3M	5.7M	7.3M	4.4M
Total Revenues	893M	981M	1.02B	919M	853M
Cost of Goods Sold, Total	784M	804M	854M	777M	708M
Gross Profit	109M	177M	165M	142M	145M
Selling General & Admin Expenses, Total	90.3M	129M	134M	130M	118M
R&D Expenses	17M	21.8M	29.6M	25.8M	27.3M
Other Operating Expenses	2.5M	-	-400K	-	-4.4M
Other Operating Expenses, Total	110M	151M	163M	156M	141M
Operating Income	-700K	25.7M	1.7M	-13.1M	3.5M
Interest Expense, Total	-1M	-1.7M	-8M	-16.9M	-3.4M
Interest And Investment Income	200K	100K	800K	6M	700K
Net Interest Expenses	-800K	-1.6M	-7.2M	-10.9M	-2.7M
Currency Exchange Gains (Loss)	1.1M	-1.1M	1.5M	2.3M	2.9M
Other Non Operating Income (Expenses)	100K	8.1M	0	-6M	-3.3M
EBT, Excl. Unusual Items	-300K	31.1M	-4M	-27.7M	400K
Restructuring Charges	-13.4M	-6.1M	-12.3M	-93.1M	-60.9M
Asset Writedown	-	-21.8M	-226M	-18.8M	-77.8M
Legal Settlements	-900K	-	-	-	-
EBT, Incl. Unusual Items	-14.6M	3.2M	-243M	-140M	-138M
Income Tax Expense	1.2M	18.2M	-53M	-9M	72.9M
Earnings From Continuing Operations	-15.8M	-15M	-190M	-131M	-211M
Net Income to Company	-15.8M	-15M	-190M	-131M	-211M
Net Income - (IS)	-15.8M	-15M	-190M	-131M	-211M
Net Income to Common Incl Extra Items	-15.8M	-15M	-190M	-131M	-211M
Net Income to Common Excl. Extra Items	-15.8M	-15M	-190M	-131M	-211M
Per Share Items
Net EPS - Basic	-0.18	-0.16	-2.01	-1.38	-2.23
Basic EPS - Continuing Operations	-0.18	-0.16	-2.01	-1.38	-2.23
Basic Weighted Average Shares Outstanding	90M	93.7M	94.2M	94.5M	94.7M
Net EPS - Diluted	-0.18	-0.16	-2.02	-1.38	-2.23
Diluted EPS - Continuing Operations	-0.18	-0.16	-2.02	-1.38	-2.23
Diluted Weighted Average Shares Outstanding	90M	93.7M	94.2M	94.5M	94.9M
Normalized Basic EPS	-0	0.21	-0.03	-0.18	0
Normalized Diluted EPS	-0	0.21	-0.03	-0.18	0
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	59M	109M	290M	48.3M	130M
EBITA	-700K	25.7M	2.8M	-13.1M	3.5M
EBIT	-700K	25.7M	1.7M	-13.1M	3.5M
EBITDAR	-	114M	297M	53.8M	135M
Effective Tax Rate - (Ratio)	-8.22	568.75	21.84	6.45	-52.71
Total Current Taxes	18.3M	9.2M	1.4M	4M	4M
Total Deferred Taxes	-17.1M	9M	-54.4M	-13M	68.9M
Normalized Net Income	-188K	19.44M	-2.5M	-17.31M	250K
Interest Capitalized	-	-	300K	700K	1M
Interest on Long-Term Debt	400K	400K	300K	300K	400K
Non-Cash Pension Expense	900K	600K	1.3M	2.5M	3M
Supplemental Operating Expense Items
Selling and Marketing Expenses	34M	37.7M	40.9M	37.6M	35.5M
General and Administrative Expenses	55.4M	90.5M	90M	89.4M	80.3M
Research And Development Expense From Footnotes	17M	21.8M	29.6M	25.8M	27.3M
Net Rental Expense, Total	-	4.9M	7.3M	5.5M	5M
Imputed Operating Lease Interest Expense	-	920K	2.8M	5.26M	2.62M
Imputed Operating Lease Depreciation	-	3.98M	4.5M	243K	2.38M
Maintenance & Repair Expenses, Total	-	61.9M	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	12.9M	7.9M	3.4M	2M
Stock-Based Comp., Other (Total)	1.8M	-	-	-	-
Total Stock-Based Compensation	1.8M	12.9M	7.9M	3.4M	2M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	10.3M	74.5M	34.5M	73M	114M
Total Cash And Short Term Investments	10.3M	74.5M	34.5M	73M	114M
Accounts Receivable, Total	250M	271M	217M	161M	115M
Other Receivables	29.4M	67.7M	67.5M	34M	35.5M
Total Receivables	279M	338M	284M	195M	150M
Inventory	570M	595M	645M	524M	495M
Prepaid Expenses	1.3M	3.3M	7.2M	4.3M	3.3M
Other Current Assets, Total	44.5M	12.8M	8.4M	33.5M	5.7M
Total Current Assets	905M	1.02B	979M	830M	768M
Gross Property Plant And Equipment	2.19B	2.25B	2.41B	2.26B	2.31B
Accumulated Depreciation	-1.56B	-1.62B	-1.9B	-1.73B	-1.82B
Net Property Plant And Equipment	632M	639M	506M	529M	487M
Goodwill	-	-	4.6M	-	-
Other Intangibles, Total	26.8M	28.7M	34.2M	38.1M	26.7M
Deferred Tax Assets Long-Term	45.3M	29.6M	79.2M	87.2M	18.5M
Other Long-Term Assets, Total	9.7M	14.9M	9M	4.6M	4.5M
Total Assets	1.62B	1.74B	1.61B	1.49B	1.3B
Liabilities
Accounts Payable, Total	190M	220M	160M	105M	110M
Accrued Expenses, Total	57M	70M	53.9M	58.4M	51.2M
Short-term Borrowings	1.4M	100M	205M	50.6M	45.5M
Current Portion of Leases	4M	4.5M	4.6M	5.3M	3.6M
Current Income Taxes Payable	7.7M	11.7M	300K	400K	1.4M
Unearned Revenue Current, Total	10.4M	6.6M	16.3M	37.1M	12.6M
Other Current Liabilities	118M	44M	68.8M	71.7M	70.3M
Total Current Liabilities	388M	456M	509M	328M	295M
Long-Term Leases	18.7M	16.2M	15.5M	13.2M	16.3M
Pension & Other Post Retirement Benefits	90.8M	61.6M	71.4M	70.5M	61.3M
Deferred Tax Liability Non Current	5.6M	6.3M	1.6M	-	-
Other Non Current Liabilities	104M	85.3M	87.3M	93.9M	144M
Total Liabilities	607M	626M	685M	506M	517M
Common Stock, Total	90M	94.6M	95.1M	95.6M	95.6M
Retained Earnings	-	-	1.86B	1.86B	1.86B
Treasury Stock	-	-1.3M	-1.9M	-2M	-2M
Comprehensive Income and Other	921M	1.02B	-1.03B	-971M	-1.17B
Total Common Equity	1.01B	1.11B	928M	984M	788M
Total Equity	1.01B	1.11B	928M	984M	788M
Total Liabilities And Equity	1.62B	1.74B	1.61B	1.49B	1.3B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	94.03M	94.46M	94.84M	95.23M	95.19M
ECS Total Common Shares Outstanding	90M	94.46M	94.84M	95.23M	95.19M
Book Value / Share	11.24	11.75	9.78	8.23	6.18
Tangible Book Value	985M	1.08B	889M	945M	761M
Tangible Book Value Per Share	10.94	11.45	9.37	7.83	5.9
Total Debt	24.1M	121M	226M	69.1M	65.4M
Net Debt	13.8M	46.3M	191M	-3.9M	-48.4M
Debt Equivalent of Unfunded Proj. Benefit Obligation	116M	61.5M	71.4M	70.5M	64.5M
Debt Equivalent Oper. Leases	-	39.2M	58.4M	44M	40M
Account Code - Inventory Valuation	6	6	6	3	3
Inventories - Raw Materials, Total	99M	104M	105M	79.3M	69.4M
Inventories - Work In Process, Total	276M	303M	334M	333M	297M
Inventories - Finished Goods, Total	227M	220M	238M	154M	174M
Land - (BS)	16.7M	15.9M	16.3M	2.4M	2.4M
Buildings, Total	299M	302M	321M	299M	314M
Machinery, Total	1.67B	1.71B	1.8B	1.75B	1.79B
Full Time Employees	2.94K	3.39K	3.3K	3.19K	2.96K
Accumulated Allowance for Doubtful Accounts (Supple)	2.3M	1.6M	4.1M	5.7M	5.8M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	-15.8M	-15M	-190M	-131M	-211M
Depreciation & Amortization - CF	65.8M	89.1M	294M	68.1M	132M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	1.1M	-	-
Depreciation & Amortization, Total	65.8M	89.1M	295M	68.1M	132M
Amortization of Deferred Charges, Total - (CF)	1.3M	5.4M	8M	8.7M	8.1M
(Gain) Loss From Sale Of Asset	-	-	-	-	-4.4M
Asset Writedown & Restructuring Costs	8.9M	-	-	-	-
Stock-Based Compensation (CF)	1.8M	10.9M	4.9M	2.7M	1.5M
Other Operating Activities, Total	-19.6M	20.8M	-44.3M	14.2M	81.9M
Change In Accounts Receivable	-131M	-29.6M	48.9M	52.2M	45.4M
Change In Inventories	14M	-31.7M	-40.4M	94M	38.9M
Change In Accounts Payable	88.9M	21.4M	-52.9M	-46.8M	1.6M
Change in Other Net Operating Assets	57.2M	-26.5M	-24.3M	60.4M	34.3M
Cash from Operations	71.5M	44.8M	5.1M	123M	128M
Capital Expenditure	-88.6M	-106M	-152M	-108M	-78.5M
Sale of Property, Plant, and Equipment	700K	-	-	-	-
Cash Acquisitions	-	-	-4.5M	-	-
Divestitures	-	-	-	-	1.5M
Sale (Purchase) of Intangible assets	-	-7.4M	-13.9M	-	-
Other Investing Activities, Total	-	-53.6M	32.9M	-	-
Cash from Investing	-87.9M	-167M	-137M	-108M	-77M
Short Term Debt Issued, Total	1.3M	98.5M	105M	-	-
Long-Term Debt Issued, Total	-	-	-	197M	-
Total Debt Issued	1.3M	98.5M	105M	197M	-
Short Term Debt Repaid, Total	-	-	-	-155M	-5M
Long-Term Debt Repaid, Total	-2.5M	-4.6M	-7.3M	-5.5M	-5.4M
Total Debt Repaid	-2.5M	-4.6M	-7.3M	-160M	-10.4M
Issuance of Common Stock	27.8M	98M	-	-	-
Repurchase of Common Stock	-	-1.3M	-600K	-100K	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-100K	-2.8M	-4.9M	-10.2M	-2.9M
Cash from Financing	26.5M	188M	92.2M	26.5M	-13.3M
Foreign Exchange Rate Adjustments	-	-1M	-	-600K	300K
Miscellaneous Cash Flow Adjustments	200K	-	-	-100K	100K
Net Change in Cash	10.3M	64.2M	-40M	40.7M	38.6M
Supplemental Items
Cash Interest Paid	-	2.9M	6.9M	16.9M	3.7M
Cash Income Tax Paid (Refund)	-	2.6M	-	-	-
Levered Free Cash Flow	87.24M	-75.2M	92.46M	115M	157M
Unlevered Free Cash Flow	87.86M	-74.14M	97.46M	125M	160M
Change In Net Working Capital	-108M	83.8M	48.7M	-161M	-93.4M
Net Debt Issued / Repaid	-1.2M	93.9M	97.7M	36.8M	-10.4M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	-0.03	0.96	0.06	-0.53	0.16
Return on Total Capital	-0.04	1.41	0.09	-0.74	0.23
Return On Equity %	-1.58	-1.41	-18.62	-13.67	-23.84
Return on Common Equity	-1.58	-1.41	-18.62	-13.67	-23.84
Margin Analysis
Gross Profit Margin %	12.22	18.03	16.15	15.49	17
SG&A Margin	10.11	13.19	13.12	14.11	13.9
EBITDA Margin %	6.61	11.09	28.47	5.25	15.21
EBITA Margin %	-0.08	2.62	0.27	-1.43	0.41
EBIT Margin %	-0.08	2.62	0.17	-1.43	0.41
Income From Continuing Operations Margin %	-1.77	-1.53	-18.62	-14.21	-24.77
Net Income Margin %	-1.77	-1.53	-18.62	-14.21	-24.77
Net Avail. For Common Margin %	-1.77	-1.53	-18.62	-14.21	-24.77
Normalized Net Income Margin	-0.02	1.98	-0.25	-1.88	0.03
Levered Free Cash Flow Margin	9.77	-7.67	9.07	12.46	18.47
Unlevered Free Cash Flow Margin	9.84	-7.56	9.57	13.61	18.72
Asset Turnover
Asset Turnover	0.55	0.58	0.61	0.59	0.61
Fixed Assets Turnover	1.47	1.54	1.78	1.78	1.68
Receivables Turnover (Average Receivables)	3.92	3.75	4.16	4.82	6.14
Inventory Turnover (Average Inventory)	1.36	1.38	1.38	1.33	1.39
Short Term Liquidity
Current Ratio	2.33	2.24	1.92	2.53	2.6
Quick Ratio	0.75	0.9	0.63	0.82	0.9
Operating Cash Flow to Current Liabilities	0.18	0.1	0.01	0.37	0.44
Days Sales Outstanding (Average Receivables)	93.19	97.29	87.81	75.9	59.43
Days Outstanding Inventory (Average Inventory)	268.64	264.26	264.79	275.39	262.88
Average Days Payable Outstanding	76.1	90.06	76.52	73.76	57.92
Cash Conversion Cycle (Average Days)	285.73	271.49	276.08	277.53	264.39
Long Term Solvency
Total Debt/Equity	2.38	10.88	24.31	7.03	8.3
Total Debt / Total Capital	2.33	9.81	19.55	6.56	7.66
LT Debt/Equity	1.85	1.46	1.67	1.34	2.07
Long-Term Debt / Total Capital	1.81	1.32	1.34	1.25	1.91
Total Liabilities / Total Assets	37.51	36.05	42.46	33.97	39.6
EBIT / Interest Expense	-0.7	15.12	0.21	-0.78	1.03
EBITDA / Interest Expense	65.1	67.53	37.08	3.25	39.97
(EBITDA - Capex) / Interest Expense	-23.5	4.94	18.1	-3.14	16.88
Total Debt / EBITDA	0.37	1.05	0.76	1.26	0.48
Net Debt / EBITDA	0.21	0.4	0.64	-0.07	-0.36
Total Debt / (EBITDA - Capex)	-1.03	14.38	1.56	-1.3	1.14
Net Debt / (EBITDA - Capex)	-0.59	5.51	1.32	0.07	-0.84
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.48	9.87	3.87	-9.79	-7.25
Gross Profit, 1 Yr. Growth %	20.55	62.14	-6.95	-13.49	1.76
EBITDA, 1 Yr. Growth %	5.17	63.86	141.35	-84.12	103.61
EBITA, 1 Yr. Growth %	0	-3.77K	-89.11	-1.11K	-126.72
EBIT, 1 Yr. Growth %	0	-3.77K	-93.39	-1.11K	-126.72
Earnings From Cont. Operations, 1 Yr. Growth %	150.79	85.19	1.16K	-31.15	61.72
Net Income, 1 Yr. Growth %	150.79	85.19	1.16K	-31.15	61.72
Normalized Net Income, 1 Yr. Growth %	-175	-10.47K	-112.86	592.5	-101.44
Diluted EPS Before Extra, 1 Yr. Growth %	157.14	77.87	1.16K	-31.58	61.37
Accounts Receivable, 1 Yr. Growth %	21.42	8.24	-19.84	-25.63	-28.77
Inventory, 1 Yr. Growth %	-2.5	4.42	8.42	-18.7	-5.53
Net Property, Plant and Equip., 1 Yr. Growth %	7.84	1.2	-20.84	4.58	-8.07
Total Assets, 1 Yr. Growth %	1.09	7.03	-7.13	-7.62	-12.41
Tangible Book Value, 1 Yr. Growth %	0.08	9.34	-17.81	6.36	-19.47
Common Equity, 1 Yr. Growth %	2.23	9.28	-16.44	6.01	-19.88
Cash From Operations, 1 Yr. Growth %	-26.14	-37.34	-88.62	2.31K	4.56
Capital Expenditures, 1 Yr. Growth %	0.23	-4.74	42.67	-18.67	-27.31
Levered Free Cash Flow, 1 Yr. Growth %	418.11	-291.65	-222.96	-8.58	61.75
Unlevered Free Cash Flow, 1 Yr. Growth %	403.15	-285.98	-231.46	-3.84	47.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.26	1.9	6.83	-3.2	-8.52
Gross Profit, 2 Yr. CAGR %	11.6	39.81	22.83	-10.28	-6.17
EBITDA, 2 Yr. CAGR %	6.21	39.26	109.02	-36.61	-34.7
EBITA, 2 Yr. CAGR %	-55.28	505.92	100	-28.6	64.08
EBIT, 2 Yr. CAGR %	-55.28	505.92	55.84	-28.6	64.08
Earnings From Cont. Operations, 2 Yr. CAGR %	151.4	54.3	383.94	195.07	5.51
Net Income, 2 Yr. CAGR %	151.4	54.3	383.94	195.07	5.51
Normalized Net Income, 2 Yr. CAGR %	-69.38	781.76	265.15	-5.62	-68.38
Diluted EPS Before Extra, 2 Yr. CAGR %	154.42	51.23	373.76	193.82	5.07
Accounts Receivable, 2 Yr. CAGR %	9.06	14.64	-6.86	-22.79	-27.22
Inventory, 2 Yr. CAGR %	-2.32	0.9	6.41	-6.11	-12.36
Net Property, Plant and Equip., 2 Yr. CAGR %	4.99	4.47	-10.49	-9.01	-1.95
Total Assets, 2 Yr. CAGR %	1.32	4.13	-0.3	-7.37	-10.05
Tangible Book Value, 2 Yr. CAGR %	-1.48	4.85	-5.2	-6.5	-7.46
Common Equity, 2 Yr. CAGR %	-0.33	5.93	-4.44	-5.88	-7.84
Cash From Operations, 2 Yr. CAGR %	43.13	-31.97	-73.29	65.63	401.96
Capital Expenditures, 2 Yr. CAGR %	4.07	9.71	16.58	0.75	-23.12
Levered Free Cash Flow, 2 Yr. CAGR %	-	111.33	53.51	23.42	12.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	106.05	56.36	29.91	10.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	2.32	2.56	0.98	-4.57
Gross Profit, 3 Yr. CAGR %	-	26.4	22.07	9.29	-6.44
EBITDA, 3 Yr. CAGR %	-	27.66	72.93	-10.07	2.57
EBITA, 3 Yr. CAGR %	-	94.37	58.74	165.5	-48.55
EBIT, 3 Yr. CAGR %	-	94.37	34.42	165.5	-48.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-	81.71	211.11	152.63	141.47
Net Income, 3 Yr. CAGR %	-	81.71	211.11	152.63	141.47
Normalized Net Income, 3 Yr. CAGR %	-	113.4	115.44	351.98	-76.57
Diluted EPS Before Extra, 3 Yr. CAGR %	-	79.22	206.73	148.56	140.62
Accounts Receivable, 3 Yr. CAGR %	-	8.78	1.75	-13.59	-24.84
Inventory, 3 Yr. CAGR %	-	-0.12	3.35	-2.73	-5.92
Net Property, Plant and Equip., 3 Yr. CAGR %	-	3.71	-4.76	-5.72	-8.7
Total Assets, 3 Yr. CAGR %	-	3.26	0.24	-2.8	-9.08
Tangible Book Value, 3 Yr. CAGR %	-	2.16	-3.32	-1.5	-11.04
Common Equity, 3 Yr. CAGR %	-	2.93	-2.12	-1.07	-10.8
Cash From Operations, 3 Yr. CAGR %	-	8.68	-62.51	19.79	42.08
Capital Expenditures, 3 Yr. CAGR %	-	9.16	19.75	-1.12	-9.64
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	76.43	42.92	27.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	77.38	46.41	29.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	0.07	-2.03
Gross Profit, 5 Yr. CAGR %	-	-	-	10.2	9.87
EBITDA, 5 Yr. CAGR %	-	-	-	-1.58	18.25
EBITA, 5 Yr. CAGR %	-	-	-	30.21	37.97
EBIT, 5 Yr. CAGR %	-	-	-	30.21	37.97
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	120.6	101.87
Net Income, 5 Yr. CAGR %	-	-	-	120.6	101.87
Normalized Net Income, 5 Yr. CAGR %	-	-	-	53.98	0
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	118.41	99.82
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-5.16	-11.01
Inventory, 5 Yr. CAGR %	-	-	-	-2.56	-3.25
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-1.58	-3.64
Total Assets, 5 Yr. CAGR %	-	-	-	-1.13	-4.01
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-1.4	-5
Common Equity, 5 Yr. CAGR %	-	-	-	-0.69	-4.45
Cash From Operations, 5 Yr. CAGR %	-	-	-	28.63	5.83
Capital Expenditures, 5 Yr. CAGR %	-	-	-	5.71	-2.35
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	56.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	55.66